Yarrow Bioscience YARW
NASDAQ YARW
$37.93 -2.67 (-6.58%)
At close: Aug 20, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Operating Leases (2019 - 2024)

Yarrow Bioscience's (YARW) quarterly Operating Leases came in at $99000.0 in Q4 2024, little changed YoY from $99000.0 in Q1 2024, and up 296.0% on a QoQ basis from $25000.0 in Q2 2024.

Yarrow Bioscience (YARW) Operating Leases (2019 - 2024) Analysis & Trends

Yarrow Bioscience (YARW) has 5 years of Operating Leases data on file, last reported at $99000.0 in Q4 2024.

  • Quarterly Operating Leases changed 0.0% year-over-year to $99000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $99000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $99000.0, changed 0.0% from the prior year.
  • Operating Leases advanced to $99000.0 in Q4 2024, from $25000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $2.2 million in Q3 2020 to a low of $25000.0 in Q2 2024.
  • A 4-year average of $762000.0 and a median of $775000.0 in 2021 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2020 — Operating Leases soared 630.0% — and 2021, when it tumbled 64.61%.
  • Tracing YARW's Operating Leases over 4 years: stood at $853000.0 in 2020, then fell by 9.14% to $775000.0 in 2021, then tumbled by 87.23% to $99000.0 in 2023, then changed by 0.0% to $99000.0 in 2024.
  • The last three Operating Leases figures came in at $99000.0 (Q4 2024), $25000.0 (Q2 2024), and $63000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Yarrow Bioscience 32.54 Mn 9.62 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 99,000.00
Jun 30, 2024 25,000.00
Mar 31, 2024 63,000.00
Dec 31, 2023 99,000.00
Sep 30, 2021 775,000.00
Jun 30, 2021 812,000.00
Mar 31, 2021 1.43 Mn
Dec 31, 2020 853,000.00
Sep 30, 2020 2.19 Mn
Jun 30, 2020 1.31 Mn
Mar 31, 2020 727,000.00
Dec 31, 2019 653,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 715,000.00
Mar 31, 2019 684,000.00